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Executive summary

1. Executive summary
This report documents a service evaluation of Marie
Stopes (MS) India’s mobile outreach programme in the
state of Rajasthan, which was conducted by the
Population Council in India between March and
October 2012. This study was made possible through
the United States Agency for International
Development (USAID) funded Support for International
Family Planning Organizations - Marie Stopes
International (SIFPO-MSI) project. It provides
important findings on the safety and effectiveness of
MS India’s outreach programme in expanding choice
and access to long-acting reversible contraception
(LARC) methods and voluntary surgical permanent
methods (PM) of contraception, as well as
recommendations for MS India and other family
planning programmes to consider in scaling up and
strengthening provision of mobile outreach services.
Family planning in India
India has a modern contraceptive prevalence rate of
48% [2]. One in five married women has an unmet
need for family planning; 13% of married women have
an unmet need for contraception to limit childbearing,
while 7% of married women have an unmet need for
spacing [12]. Unmet need is more acute in rural
settings where health services and personnel are
lacking. To address this, in recent decades the
Government of India (GOI) has focused on expanding
access to voluntary Family planning services. This was
most recently articulated in the National Population
Policy (NPP 2000), which emphasises the need to
continue to provide reproductive healthcare and family
planning services using a voluntary, informed consent
and target-free approach. NPP 2000 has been
bolstered by GOI strategies aimed at reducing the cost
burden of family planning services, in particular costs
and barriers associated with higher-cost permanent
methods.
The family planning method mix in India remains
dominated by voluntary permanent methods. Currently,
nearly three quarters (71%) of modern method family
planning users in India have opted for female
sterilisation. Despite high levels of effectiveness and
user satisfaction [3], LARC uptake is very low, with
only 2% of women using the intrauterine device (IUD).
The contraceptive implant is not yet registered in India;
1

therefore, use of LARC is limited to IUDs. A lack of
access to and uptake of LARC stems from weak
political support, prevailing misconceptions amongst
potential users, and poor provider counselling.
Contraceptive injectables are available in private
sector facilities but are not offered in the public sector
where short-acting methods are limited to oral
contraceptive pills and condoms. Emergency
contraception is also available. In India, uptake of
condoms stands at 6% and uptake of pills at 4% [12].
Permanent methods for males (vasectomy) represent
approximately 1% of modern method use [12].
Despite a decline in the country’s total fertility rate
(TFR), this has not translated to improved maternal
and infant health, partly due to early marriage and
short intervals between births. In order to improve
women’s health and enable couples to achieve desired
family size, it is crucial to improve current low
contraceptive access and limited choice among family
planning methods, particularly in rural and poor
regions of India.

Marie Stopes India
Marie Stopes India was established in 2008 to work in
partnership with the GOI health departments to
provide reproductive health and family planning
services to poor men and women living in rural and
remote areas. Partnership with non-governmental
service providers is a key strategic approach for GOI
implementation of frameworks such as the National
Population Policy (NPP 2000).
Although the GOI offers family planning services
through public sector facilities and has been active
delivering permanent methods through outreach, GOI
capacity is limited and, therefore, significant demand
for PMs and LARC in rural districts remains unmet.
The private (commercial) health sector in India is
active, yet scarcity of private clinics in rural regions
somewhat limits the private sector’s role in service
delivery to the hardest to reach and poorest clients.
Through collaboration with the GOI to provide outreach
services, MS India fills gaps in existing service
availability. These gaps, which MS India address
through mobile outreach, centre on access to IUDs,
tubal ligations (TL), and vasectomy. Contraceptive

As cited in the MoHFW, Family Welfare Statistics in India (GOI, 2011) a total of 338,574 TLs and 407,122 IUDs were provided in the state of Rajasthan
for the period 2010 / 2011 (pp 170-171, tables B8 and B9).

Executive summary

implants are not yet registered in India, and injectables
are not offered in public sector facilities. Condoms,
oral contraceptive pills, and emergency contraception
are available in public sector facilities (alongside MS
India provision of PMs and LARC). During government
stock-outs, MS India supports the public sector by
supplementing their stock of short-acting methods.
MS India currently works across Rajasthan, Uttar
Pradesh and Madhya Pradesh states. In 2011, MS
India provided a total of 109,074 TLs and 34,091 IUD
procedures, which contributed to 32% of the total TLs
and 8% of all IUDs provided in the state of Rajasthan
in 2011 . [4] Data from client exit interviews
demonstrates that on average, 80% of MS India’s
outreach clients were not using a modern family
planning method before taking up a service through
outreach.

Study Objectives and Design
While expanding the availability of family planning
methods is important, it is equally important that the
quality of these services is maintained to ensure that
family planning procedures are safe and meet the
expectations of clients in outreach settings. Under the
auspices of the USAID-funded SIFPO-MSI project,
Population Council carried out an evaluation of MS
India’s mobile outreach services to provide a better
understanding of the safety, acceptability, and profiles
of clients accessing contraceptive services through
MSI’s outreach service delivery in rural areas.
Findings from the study will inform and improve further
family planning outreach programming.
The study focused on TL and IUD procedures
provided by MS India in four districts of Rajasthan.
These methods were chosen as they represent the
vast majority of MS India’s contribution to the method
mix of family planning services offered at outreach
sites. Vasectomy services were excluded from the
study due to sporadic client numbers.
Between March and October 2012, 875 women
receiving a TL and 402 women receiving an IUD
procedure via MS India outreach were recruited for the
study. Clients were interviewed before and
immediately after their procedure at the outreach site,
and on day 15 post procedure, about their side effects
and satisfaction. Women who received an IUD were
also interviewed at day 90 where information was

collected about method discontinuation and reasons
for IUD removal.
Study Findings and Recommendations
The study demonstrates that TL and IUD procedures
can be provided safely and effectively in rural and hard
to reach areas of Rajasthan through MS India’s mobile
outreach approach. In the selected cohort no major
complications were reported and side effects were
generally mild or moderate. The incidence of side
effects and complications observed in this study are
largely in line with published literature.[1,5-10] Most of
the clients were willing to recommend the service to
other women, signalling strong client satisfaction. The
majority of women were from rural areas (81% of TL
clients; 72% of IUD clients), poor households and had
no education (53% of TL clients; 30% of IUD clients),
which shows that through this service MS India is also
fulfilling its objective in reaching underserved women
in rural settings. Before taking up a family planning
method from MS India mobile outreach, 63% of TL
clients and 41% of IUD clients had never used modern
contraception.

These findings support the recommendation that, in
India, family planning programmes should consider
mobile outreach models to broaden the range of
services available in rural and hard to reach areas.
Through mobile outreach, MS India is able to add
LARC and PMs to the method mix available in
government facilities, complementing the governmentprovided short-acting methods to offer clients a wider
choice. In addition to service provision, MS India
should continue to advocate for the registration of
implants, wider availability of injectables, and promote
access to a broader method mix in India.

iv
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Introduction and background

2. Introduction and
background
2.1 Family planning method mix in India
There is a large unmet need for voluntary family
planning in India, with an estimated 32 million or 13% of
currently married women who want to limit their children
and a further 7% who would like to space the time
interval between multiple births, but who are not using
any modern method of contraception. [12] Over recent
decades, the country has seen a focus, largely driven
by the GOI, on expanding access to voluntary family
planning methods including permanent methods (PMs).
Unique to India, the adoption of female sterilization,
which has steadily increased over the past two
decades, tends to occur at a relatively young age
following early marriage and childbearing, [13] and
after the birth of at least one son. [2] More than half of
women who choose a TL have the procedure before
they reach 26 years of age, and in some states the
average is as young as 23 years. [2]

In Rajasthan and more broadly in India, TLs represent
a significant proportion of the contraceptive method
mix (see Table 1). Low uptake of LARCs is due to
multiple factors including weak political commitment
for these methods, registration barriers, myths and
misconceptions, and poor provider counselling.
LARCs, such as IUDs and implants have high levels of
effectiveness and user satisfaction globally [3, 15] but
in India only 2% of women use IUDs and none use
implants (see Table 1). Globally, the IUD has the
lowest discontinuation rate, compared to other shortand long-acting methods of contraception (a review of
DHS data from 18 developing countries showed that
the overall discontinuation rate of the IUD was 15.5%
at 12 months following insertion). Low discontinuation
can probably be credited to the IUD’s low failure rate
as well as the necessity to visit a health professional to
have it removed. [16]

TABLE 1: Family planning data for Rajasthan State and India

2
3

4

Indicator

Rajasthan

India

Total fertility rate

3.1

2.5

Contraceptive prevalence rate (CPR) for modern methods (%) 2

55.3

48.0

Female sterilisation

42.6

35.8

IUD

1.3

1.8

Male sterilisation

0.6

1.1

Pill

2.7

3.6

Injection3

0.2

0.1

Condom

7.7

5.5

Traditional methods (withdrawal, periodic abstinence)

2.7

6.4

Total unmet need for family planning

16.9

20.5

Unmet need for spacing births

7.0

7.2

Unmet need for limiting births

9.9

13.3

Maternal mortality ratio (MMR) 4

318 per 100,000 live
births

212 per 100,000 live
births

Source: International Institute for Population Sciences (IIPS). 2010. District Level Household Survey (DLHS-3), 2007-08: India. Mumbai. IIPS.
Source: International Institute of Population Sciences (IIPS) and Macro International. 2008. National Family Health Survey (NFHS-3), 2005-06:
Mumbai: IIPS and Macro International.
Source: RGI, 2011. Special bulletin on maternal mortality in India. SRS Bulletin. Office of Registrar General, Ministry of Home Affairs, India. Accessed
from http://www.censusindia.gov.in/vital_statistics/SRS_Bulletins/Final-MMR%20Bulletin-2007-09_070711.pdf
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LARC methods offer women the benefit of reduced
risk of poor maternal and child health outcomes
resulting from frequent and/ or many births [3] without
women needing to rely on daily or per-sexualencounter action or on re-supply of contraceptive
commodities. As reversible methods, LARC offer these
benefits for women who wish to space or delay
pregnancies. Offering LARC in the context of access
to TL, vasectomy, and short-acting methods is critical
to meet the differing needs and preferences of women
and men, especially as needs may change over the
span of life stages. Given the myriad of reasons for low
uptake of LARC and relatively low uptake of shortacting methods in India, it is necessary to advocate
and build capacity at multiple levels of the health
system for a broader method mix and wider choice in
contraceptive options.

2.2 Access to family planning services
Although the majority of users of modern contraception
in India are TL adopters (71% nationally and 77% in
Rajasthan), access to a full range of family planning
methods, including permanent methods, remains
limited in under-served areas. Government health
centres offer condoms and oral contraceptive pills but
often lack providers with the clinical and counselling
skills to effectively offer IUDs and do not have
providers capable of delivering tubal ligation and
vasectomy procedures. Injectables are not available in
government facilities and contraceptive implants are
not registered in India.
Private (commercial) sector facilities offer a wider
range of method options, including condoms, pills,
injectables, IUD and permanent methods. However,
fees charged in the private sector can pose financial
barriers for poor clients, and the scarcity of private
facilities in rural areas limits the private (commercial)
sector’s ability to address unmet need in these
regions.
To address the gaps in access for rural and underserved populations, the GOI engages in partnership
with non-governmental service providers as a strategic
approach to achieving key policy frameworks such as
the National Population Policy (NPP 2000). Mobile
outreach by MS India and other non-governmental
service delivery organisations (e.g. FPAI) to provide
family planning methods which government is unable

to offer in rural areas represents an important strategy
for filling gaps in method access. In Rajasthan, MS
India is the only organisation providing mobile family
planning services. The Family Planning Association of
India (FPAI) implements mobile family planning
outreach in other states.

2.3 Marie Stopes India
Marie Stopes India was established in 2008 to work in
partnership with the GOI health departments to
provide reproductive health and family planning
services to poor men and women living in rural and
remote areas of Rajasthan, Uttar Pradesh and Madhya
Pradesh states. In Rajasthan, MS India provides
outreach services in partnership with the government
in 11 districts: Jaipur, Ajmer, Alwar, Nagaur, Sikar,
Rajsamand, Bharatpur, Udaipur, Chittorgarh,
Banswara, and Pratapgarh.
Delivering PMs and LARC, MS India complements the
public sector’s provision of short-acting methods
offered at government facilities and at the community
level by community health workers (ASHA, AWW, and
ANM). In 2011–12, the number of services performed
by MS India increased and the program has recently
grown from six to 11 outreach teams covering 372 sites
operating in eleven districts. In 2011 32% of the TLs
and 8% of the IUDs provided in the state of Rajasthan
were obtained from MS India.
MS India is well-positioned for sexual and reproductive
health service delivery. As a member of the Marie
Stopes International (MSI) global partnership, MS India
promotes and adheres to MSI’s global clinical protocols
[21], training, monitoring, and standardised quality
assurance mechanisms. MS India emphasises client
focus, meaning that clinical quality, client trust and
respect, and overall client experience are key. To
ensure adherence to these standards, MS India
regularly conducts peer assessments, internal clinical
audits, and external clinical quality assurance using the
MSI global monitoring framework, the Quality Technical
Assistance (QTA). QTA uses a standardised tool to
assess clinical quality compliance in service delivery
covering counselling, service provision, infection
prevention, management of medical emergencies,
clinical governance, client focus, and management of
equipment and supplies. For each annual QTA audit, a
random sample of MS India providers from each

02
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The Marie Stopes International (MSI) outreach model

In order to increase access to family planning and
broaden the contraceptive method mix available to
underserved populations, MSI uses a mobile
outreach model in over twenty countries to provide
affordable, high quality family planning services,
including LARC and PMs, to men and women living
in rural and hard to reach areas. Sensitisation and
information provision about the outreach services
and the different contraceptive methods are
conducted in advance of the outreach visits, often
with the assistance from community health workers.
Outreach teams work in coordination with local
governments and utilise existing public health
facilities (or tents where no facilities are available).
The frequency, with which outreach teams return to
a location, as well as the duration of each visit,
depends on the level of demand. MSI mobile
outreach programmes follow global clinical quality
standards and implement rigorous follow up systems
that allow women to access medical advice after
their treatment.

service delivery area is assessed. Regular trainings for
clinical providers ensure that skills are always up-todate.
MS India mobile outreach services are known as
Clinical Outreach Teams (COT). These seven-member
teams are comprised of three doctors - a surgeon, a
medical officer, an anaesthetist (required by GOI) –
one male and one female nurse, one health care
assistant, and one driver. In line with the GOI protocol
only doctors are permitted to provide TLs whereas
nurses or Auxiliary Nurse Midwives (ANMs) are
authorized and trained to provide IUD services. The
COTs provide services in government facilities such as
primary health centres and community health centres,
and men and women in the outreach catchment area
are informed about the services by MS India’s
Interpersonal Communicators (IPCs) and government
community health workers known as Accredited Social
Health Activists (ASHAs).
Both IPCs and ASHAs are members of the community
who create awareness of MS India’s outreach services

and provide information about family planning
methods. The IPCs and ASHAs also work with the
government ANMs to mobilise clients at the outreach
site and to provide follow up care information. As a
part of the MS India outreach service protocol all
clients are informed about expected side effects,
appropriate follow up care, check-up visits with the
ANM and what to do if they experience any
complications following their procedure. Both TL and
IUD clients are also provided with a supply of
analgesia medicine to take with them post procedure.
All follow up care is carried out by the government
ANM who visit clients as informed by the MS India’s
IPCs. If complications occur beyond the management
capacity of ANMs and IPCs, clients are referred to
higher level facilities or a MS India static clinic
(depending on nature of complication and proximity).
In 2011, MS India provided a total of 109,074 TLs,
34,091 IUD procedures amounting to 1,574,781 CYP
through its outreach programme. Clients choosing
short-acting methods received their methods through
the government facility at which outreach took place,
and are therefore not represented in MS India’s direct
service provision client numbers.
MS India adheres to GOI and MSI global clinical
protocols [21] for all services provided through mobile
outreach (as well as through MS India’s other service
delivery channels). This includes comprehensive
pre-procedure group family planning counselling on a
broad range of contraceptive methods available in
India. Clients receive individual counselling to discuss
method preferences and provide detailed information
on benefits and possible side effects of the chosen
method. Client eligibility screening follows MSI clinical
standards, i.e. pregnancy status, STI screening for IUD
clients. [21] Clients who are eligible and wish to
proceed with their LARC or PM sign informed consent
forms in their local language (Hindi). For clients who
cannot read or write, the consent form is explained in
Hindi, and they thumb print their acceptance. TL,
vasectomy and IUD clinical procedures follow GOI and
MSI global clinical protocols. All clients receiving TL,
vasectomy or IUD from MS India are counselled on
managing post-procedure care and possible side
effects. Clients are provided with analgesics to take
home with them for pain management. Clients are
given the mobile phone number of an MS India clinical
staff member to contact in case of any complications
or questions.
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For TL (and vasectomy) clients, MS India contacts
them by telephone within 48 hours of their procedure.
This contact is followed up by a visit by a government
ANM on the third, fifth and 15th day after the
procedure. All IUD clients receive three visits by a
government ANM, timed to take place after their first
post-procedure menstrual cycle, three months postprocedure, and 12 months post-procedure. No
additional or different pre- or post-procedure clinical
protocols were followed for the purposes of this study.
Rather, participating clients were asked to return to the
facility where they obtained their service 15 days
post-procedure for TL clients and 15 days and 90 days
post-procedure for IUD clients. These additional visits
were non-clinical and exclusively for the purposes of
data collection for this study (see section 3.1).
While expanding contraceptive access and choice is
very important, it is equally important to maintain
quality and to ensure that services are safe and meet
the expectations of clients. MSI has a number of tools
through which service quality is routinely monitored
and client experiences and satisfaction is measured.
To further inform and improve its family planning
services, a more in-depth service evaluation among
women receiving TL and IUDs procedures via MSI
India’s mobile outreach clinics in the state of Rajasthan
was conducted and originally documented by the
Population Council in collaboration with MS India for
the Support for International Family Planning
Organizations (SIFPO)-MSI project.[17, 18] The
evaluation measured the prevalence of side effects
and complications, health seeking behaviours, and
discontinuation of IUDs, as well as the sociodemographic profile and satisfaction levels of clients
receiving these mobile outreach services.

2.4 Study aims and objectives
The overall aim of this service evaluation was to
provide more understanding about the safety,
acceptability and profile of clients who access TL and
IUD procedures via MS India’s mobile outreach in rural
areas. Through outreach in government facilities, MS
India fills gaps in access to a LARC and PMs, helping
ensure a broad contraceptive method mix is available
to women and men in rural and hard-to-reach areas.
With contraceptive implants unavailable in India
(currently not registered) and a significant but irregular
client volume for vasectomy, this study focuses on the

provision of TL and IUD, methods that provide women
with a choice of LARC and PM in rural India. This
study’s findings will help improve MS India’s provision
of services as well as inform other organisations
currently active in outreach service delivery. Specific
attention is paid to how service quality can be assured
and key programmatic areas such as counselling
messages and follow-up care mechanisms can be
strengthened and replicated.
The evaluation has five objectives:
1.		 To measure the prevalence of side effects (and the
severity of side effects) associated with TL and IUD
procedures offered in MS India’s mobile outreach
sites
2.		 To assess the discontinuation rate at 90 days post
procedure associated with IUD when delivered via
outreach services
3.		 To explore clients’ health seeking behaviours post
procedure
4.		 To determine the client profile and proportion of
“poor” clients who receive TL and IUD services via
MSI India’s outreach services; and
5.		 To evaluate clients’ satisfaction with MSI’s TL and
IUD outreach services.
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3. Methodology
3.1 Study design, location and
participants
This evaluation involved following a cohort of women
who received TL and IUD procedures from MS India
between March and October 2012 at 235 mobile
outreach sites. The sites were located in four districts
in the state of Rajasthan (Jaipur, Ajmer, Alwar and
Naguar) that were purposively selected on account of
having the highest services numbers for these
contraceptive services during 2010-2011.
Women were included in the study if they met the
following eligible criteria: received TL or IUD via
outreach services during the study period and were
willing to give written or verbal informed consent to
participate in the evaluation in their local language
(Hindi). Written consent was provided in Hindi and
verbal consent given (in Hindi) for the minority of
clients who could not read or write.
The Population Council India office followed the IRB
submission requirement. This study was exempted
from full IRB review since it was not a clinical study;
did not involve vulnerable populations; did not expose
study subjects to more than minimal risks (e.g., health,
legal, physical, social, economic, or psychological); did
not involve voice or video recording.
Sampling
At the time of the study, a total of five outreach teams
(Jaipur had two teams) were operating in the four
districts included in the study and provided both TL
and IUD services. The sample size was calculated
separately for TL and IUD procedures to ensure that
enough clients were recruited for each strata, and were
divided between the 5 teams until the sample size was
achieved.
The following formula was used for calculating the
sample size, where N is the sample size required for
the study and z1-∝/2 is the level of confidence taken as
95%.
N=

z21-∝/2 p(1-p)
x deff
d2

For the TL client sample size, the baseline indicator (p)
was taken as 3% which was based on findings from
other studies that documented a range of 1-4%
complication rate for TL procedures carried out in

similar settings [7, 8]. A margin of error (d) of 2%, a
design effect (deff) of two was used to provide a
sample size of 745. In addition, a loss to follow up rate
of 25% was then used to provide an overall sample of
800 TL clients.
For the IUD client sample size, the baseline indicator
(p) for a discontinuation rate after 90 days of 15% was
used based on an evaluation of MSI outreach services
in other countries which documented discontinuation
rates from 2.3 - 20.9%.[9] A margin of error (d) of
1.5%, a design effect (deff) of 1.5 provided a sample of
392. Considering a loss to follow up rate of 25% a total
of 400 IUD clients was required.

Survey instrument, data collection and data
analysis
A research team of two to three female investigators
and a supervisor to recruitment participants and collect
data were trained by Population Council. These
individuals were chosen from the pool of investigators
and supervisors available in the states who work with
research organisations as and when they are required
to collect data. For the purpose of this evaluation,
investigators were chosen based on their experience
with the Population Council and their availability during
the required period.
Clients were recruited for the study prior to their
procedure at the outreach site. Following informed
consent, participating clients were interviewed about
their background characteristics; knowledge and
source of information about the outreach services;
previous use of contraception; and reasons for
choosing TL or IUD, and for opting to receive the
service from MS India. After the procedure and post
recovery at the site, clients were interviewed again to
obtain feedback concerning satisfaction and any
immediate side effects associated with the procedure.
These interviews were conducted privately by
investigators appointed by the Population Council. One
of the roles of supervisors was to ensure privacy from
other clients and from MS India providers and
government staff. The post-procedure interview took
no longer than 10-12 minutes so that clients could
leave without undue delay.
Both TL and IUD clients were asked to return on day
15 post-procedure to the facility where they received

Methodology

TABLE 2: Severity level of side effects5
Level 1: Very mild

The client experiences low level of discomfort that does not require any medical
intervention

Level 2: Mild

The client experiences some level of discomfort that only requires resting or
minimum level of medical intervention such as taking pain relief from a medical
shop

Level 3: Moderate

The client experiences more frequent level of discomfort that requires attention
from medical personnel, such as a doctor

Level 4: Severe

The client experiences frequent level of discomfort that requires either further
medical check-up or hospitalization

MS India services for a follow up interview. The cost of
travel and refreshments for this interview was met by
the study. At this visit, the interviewer collected
information about side effects and any complications,
care seeking behaviour, resumption of normal
activities and satisfaction. Women receiving an IUD
were also asked to return on day 90 when information
was collected about method discontinuation. If clients
did not return to the site for a follow up interview,
attempts were made to contact respondents by
telephone if they had agreed. All women were asked in
Hindi for consent to be interviewed at both day 15 and
90.
This service evaluation recorded any incident of
complications during the procedure as indicated in the
client records and then clients’ experience of any side
effects immediately after the procedure following their
recovery period. Later, delayed side effects and
complications were recorded on day 15. Side effects
and complications were categorised by type of
symptom and severity. As the study was conducted at
outreach locations medical personnel were not
available to assess or validate the side effects at follow
up interviews. Therefore, to ensure self-reporting of
side effects was consistent and simple for respondents
to recall, the level of severity was measured by the
type of medical intervention required (if at all) to
address the problem. The definitions of level of
7

severity are shown in box 2. Minor or moderate side
effects were later differentiated from moderate or
severe complications to distinguish between expected
side effects and those that are not expected (and
possibly related to the procedure or post-operative
conditions of the woman).
The study design, development of survey tools and
data collection was managed by the Population
Council. Data was entered using the Census and
Survey Processing System (CSPro 5.0.1). Descriptive
statistical methods were conducted for analysis to
provide using the Statistical Package for Social
Sciences (SPSS 18.0).

Adapted from a similar MSI outreach evaluation: Reiss K, Nantayi L, Odong J & Ngo TD. Providing long acting and permanent contraceptives through
outreach in rural Uganda. MSI, 2012
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4. Findings
4.1 Study recruitment
The sample was recruited from women attending 235
MS India outreach service days based in a variety of
available facilities in each district, such as primary
health centres, community health centres and a MSI
clinic based in Ajmer district. The majority of services
were delivered in rural locations (81% of TLs and 72%
of IUDs) with the remaining delivered in urban and
peri-urban areas (19% of TLs and 28% of IUDs).
During the study period 1423 clients attended outreach
services for TL and IUD procedures, and out of these
women 1277 were eligible to participate in the study.
Those who were not eligible either could not go ahead
with the procedure due to medical reasons identified
during the consultation, or decided not to go ahead
with the procedure. Table 3 shows the distribution of
the sample for each of the four districts. All clients
agreed to take part and as shown in Figure 1, among
the 1277 study participants 875 received TL, and 402
had IUDs inserted. At day 15, 803 (92%) of women
who had received a TL procedure and 369 (92%) of
IUD clients completed a follow up interview. Of these,
718 TL clients and 342 IUD clients returned to the
health facility, and 85 TL clients and 27 IUD clients
were contacted through a follow up telephone
interview. Loss to follow up for both TL and IUD clients
was 8% (72 for TL and 33 IUD). At the 90 day followup for IUD clients, 98% (n=393) of the original enrolled
clients attended a follow up visit, with only 2% loss to
follow up (see Figure 1).

4.2 Socio demographic characteristics
The median age of clients was 26 years for TL clients
and 25.5 years for IUD clients. All women were
married and had one or more children (see Table 4).
Two thirds of women adopting the TL method of
contraception were between the ages of 25-29 years
(67%); whereas the age of women adopting the IUD
was more evenly spread, with less than one half aged
25-29 years (47%), and one third 20-24 years (30%),
and one quarter over the age of 30 years (23%). The
majority of TL and IUD clients had two children (40%
and 44% respectively) before adopting their method of
6

7

contraception; followed by one third (36%) of TL clients
and one quarter (22%) of IUD clients having three
children.
The majority of clients were Hindu (TL: 94% and IUD:
85%) and belonged to disadvantaged groups classified
in India as Other Backward Classes6 (TL: 53% and
IUD: 62%). One quarter of both TL (29%) and IUD
(24%) clients were from Schedule Caste / Schedule
Tribe. A large proportion of women had never been to
school or only had primary education (TL: 69% and
IUD: 47%); and considerably more women opting for
IUD than TL had achieved secondary or higher
education (53% and 31% respectively). The majority of
women were housewives (TL: 75% and IUD 84%), with
more women having a TL than IUD being a farmer or
agricultural labourer (19% and 8% respectively).
To assess the socio-economic status and poverty
levels of women the study adopted the Standard of
Living Index (SLI) that is widely used in other national
surveys of India and therefore the results are
comparable to similar population based surveys for the
state of Rajasthan7. This method is based on
assigning a measure for the household’s type of toilet
facility, source of lighting and drinking water, type of
fuel for cooking and ownership of durable goods. The
scores are then added up to produce an overall index
that ranges from a low, medium and high SLI score.
The low SLI is categorised as “poor”.
More than half of TL clients belonged to households
categorised as either low (25%) or middle income
(32%) SLI. By comparison, most IUD clients belonged
to households with a high SLI (61%) and reported a
slightly higher average monthly household income - of
Rs 8,516 RS (US$155) - than TL clients at Rs 7,400
(US$148).

Other Backward Classes is a collective term, used by the Government of India, for castes other than scheduled castes and scheduled tribes, which are
higher on social hierarchy than SC/ST but educationally and socially disadvantaged.
Such as the National Family health Surveys (NFHS) and District Level Household Surveys (DLHS) published by the International Institute for Population Sciences and ORC Macro.
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TABLE 3: Distribution of TL and IUD clients recruited for the study by district
District

Tubal ligation clients % (n)

IUD clients %(n)

Ajmer

28.0 (245)

10.4 (42)

Alwar

16.9 (148)

40.3 (162)

Jaipur

28.7 (251)

38.1 (153)

Nagaur

26.4 (231)

11.2 (45)

Total

100.0 (875)

100.0 (402)

FIGURE 1: Study cohort profile

1423 women registered for outreach services
(TL 976 & IUD 447)
Not eligible: TL
101 (10%); IUD
45 (10%)

Day 1

1277 eligible clients to participate

875 tubal ligation

402 IUD
Loss to follow up:
TL 72 (8%); IUD
33 (8%)

Day 15

Day 90

803 tubal ligation
(92%)

369 IUD
(92%)

393 IUD
(98%)

Loss to follow
up (of original
enrolled): IUD 9
(2%)
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TABLE 4: Client socio-demographic characteristics for TL and IUD services
Socio-demographic characteristics

Tubal ligation clients
(n=875) % (n)

IUD clients
(n=402) % (n)

Age of women

26.0

25.5

Under 20 (15-19)

-

0.2 (1)

20-24

17.1 (150)

29.9 (120)

25-29

67.3 (589)

46.8 (188)

30+

15.5 (136)

23.1 (93)

Number of living children [mean]

2.9

2.6

1

0.5 (5)

15.2 (61)

2

40.0 (350)

43.5 (175)

3

36.2 (317)

22.1 (89)

4 or more

23.2 (203)

19.1 (77)

Hindu

93.9 (822)

84.8 (341)

Muslim

5.9 (52)

14.7 (59)

Other religious group

0.1 (1)

0.2 (2)

Schedule caste/ Schedule tribe

29.0 (254)

23.7 (95)

Other backward classes (OBC)

53.1 (465)

61.7 (248)

General

17.8 (156)

14.6 (59)

Never attended school

52.5 (459)

30.1 (120)

Primary education (class 1-5)

16.8 (147)

16.9 (69)

Secondary education (class 6-9)

22.4 (196)

36.3 (146)

Higher education (class 10 and above)

8.3 (73)

16.7 (67)

Housewife

74.9 (655)

83.8 (337)

Farmer / agricultural laborer

19.2 (168)

7.7 (31)

Other / petty business / laborer / community health worker etc.

5.9 (52)

8.5 (34)

Low

24.7 (216)

14.2 (57)

Medium

31.7 (277)

24.4 (98)

High

43.7 (382)

61.4 (247)

Average monthly household income

Rs. 7400 (US$ 148)

Rs. 8515.71 (US$ 155)

[mean]

Religion

Caste

Education

Occupation

Standard of living index
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4.3 Knowledge and source of
information about contraception
Knowledge about contraceptive methods was quite
high among both TL and IUD clients, although the
mean number of modern methods known was higher
among IUD clients than for TL (4 and 2.8 respectively).
Most commonly cited methods for TL clients were TL,
condom and pill, with lower awareness of other LARCs
and PM methods such as IUD, DMPA and vasectomy.
Women who received an IUD expressed a wider
knowledge of other contraceptive methods. The main
sources of information about contraception for both TL
and IUD clients were from Auxiliary Nurse and
Midwives (ANMs), community based health workers
(ASHA and Anganwadi workers [AWW]), husbands,
and MSI IPC.

4.4 Previous contraceptive use

was being used. Prior to adopting a LARC or PM at the
MS India outreach service, 37% (n=325) of TL clients
and 59% (n=236) of IUD clients reported having used
contraception in the past. This finding implies that 63%
of TL clients and 41% of IUD clients were new
adopters of contraception.

4.5 Source of information about
outreach services and decision making
The majority of women learnt about MS India outreach
services from the facility based health workers or
community health workers such as ASHA, AWW and
ANM (TL 78%; 56% IUD). A lower proportion of
women learnt about the outreach services from the
MSI IPCs with 25% (n=217) of TL clients and 27%,
(n=108) of IUD clients reporting that they had been
contacted by the IPC in the community.
It is quite common for community health workers such
as ASHAs to initially approach other family members
when raising awareness about the outreach service as
the decision to adopt family planning is strongly
influenced by the husbands and parents-in-law. When
there is agreement to consider family planning, women
are then approached to discuss the services available.

The majority of women were not using a contraceptive
method before joining the study: 73% (n=639) of TL
and 54% (n=217) of IUD clients. Out of the 236 TL
clients who reported currently using a contraceptive
method only 86 (36.4%) could report how long they
had been using the method. It is also unknown what
type of family planning method (modern or traditional)

FIGURE 2: Reasons cited for choosing MSI outreach services - IUD and TL (% of women)
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The main reasons cited by women for choosing the
MSI India’s outreach services were because the
services were free (77%, n=673 for TL and 73%,
n=291 for IUD), followed by the fact that clinical staff
were available (60%, n=521 and 57%, n=228), (see
Figure 2). More than half of IUD clients (54%, n=217)
compared to one third (36%, n=315) of TL clients said
their husband’s recommendation was the reason they
used the service, and for women seeking a TL service
one third also said they were recommended by another
family member (34%, n=293). Other reasons cited for
choosing the outreach services were: financial
reimbursement for travel costs, a better facility than
alternative facility, proximity to home, and no other
service available.

(81%, n=707) and for IUD the majority of women said
their husband’s preference for this method influenced
their decision to use it (68%, n=274). Influence of the
husband or another family member on the woman’s
decision making was also commonly reported for
reasons to adopt TL (48%, n=420 and 38%, n=335
respectively). Nearly half of IUD clients also said the
influence of community health worker counselling and
having reached their desired family size were why they
chose the long acting method (45%, n=183 and 43%,
n=173). One third of TL clients (39%, n=341) also
reported that they chose to be sterilised as their
husbands did not agree to have a vasectomy.

4.6 Side effects and incidence of
complications
Reasons for choosing TL and IUD
methods

Side effects on the day of the procedure were
assessed from the clinical records to identify the types
of side effects or complications that occurred during
the procedure and post-procedural phase. Side effects
on day 15 for both TL and IUD clients, and day 90 for
IUD relied on the clients self-reporting of symptoms
and level of severity.

There was much variation between the reasons cited
by women for adopting TL and IUD methods of
contraception (see Figure 3). Women were able to give
multiple answers to why they chose their respective
family planning method. The main reason for adopting
TL was due to having reached a desired family size

FIGURE 3: Reasons cited by clients for adopting tubal ligation and IUD – multiple answers given (% of women)
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Day of Procedure
Information from clients’ records showed that among
875 TL procedures, pain was recorded for 4% (n=32)
at the time of the procedure. During the post operation
observation period, pain was recorded for 10% (87),
followed by vomiting (0.3%, n=3) and fever (0.1%, n=1)
among TL clients. Among the 402 IUD procedures
pain was recorded in 5% (n=20) of cases and
dizziness (0.5%, n=2) at the time of insertion. No
incident of complications related to both TL and IUD
surgical operations at the time of the procedure or
immediately afterwards were identified.

Following the procedure, 35% (n=308) of TL clients
and 32% (n=94) of IUD clients reported experiencing
side effects immediately after adopting their method
(see Table 5). The majority of women experienced pain
(34% and 22% for TL and IUD clients respectively),
with 12% of TL clients reporting severe pain. One TL
client also reported severe bleeding post procedure,
but this case was managed by the outreach team and
was not classified as a major incident.

TABLE 5: Types of side effects and severity reported by clients post procedure
Side effects

Tubal ligation
clients
(n=875)
% (n)

IUD clients
(n=402)
% (n)

Pain

34.4 (301)

22.1 (89)

Very mild

14.7 (129)

16.6 (67)

Mild

16.2 (142)

4.2 (17)

Moderate

1.4 (12)

0.7 (3)

Severe

2.1 (18)

0.5 (2)

4.5 (14)

1.2 (5)

1.3 (11)

0.4 (2)

0.2 (2)

0.7 (3)

-

-

0.1 (1)

-

Other (vomiting, dizziness, weakness)

0.6 (5)

-

Total women reporting any side effects

35.5 (308)

32.4 (94)

Bleeding
Very mild
Mild
Moderate
Severe
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Day 15 post procedure
On day 15, study participants were requested to return
for an interview by the Population Council research
team. This visit is separate from the routine follow-up
and check-up by conducted by MS India and
government providers that is carried out in the
community (client’s home). Information was obtained
regarding the types of side effects women were
experiencing at day 15. Women could list multiple side
effects. Among the women who had a TL who were
interviewed (n=803) 15% (n=119) reported at least one
type of side effect, and for those who had an IUD
(n=369) 21.4% (n=79) said they were still experiencing
some side effects.
Tubal ligation: As on the day of procedure pain was
reported most frequently (7%, n=54) by TL clients,
followed by abdominal pain (6%, n=50) (see Table 4).
Fewer women experienced problems with the wound
(1%, n=10), and less than 1% reported bleeding from

the wound, urinary problems and a blood clot. At day
15 the majority of side effects were identified as minor
with the majority able to seek medical care. A total of
31 women reported at least one moderate side effect
(4%) and one woman (0.1%) had a serious
complication and required hospitalization for one day
due to bleeding from the wound and infection. Out of
the 119 women who reported any side effect, the
majority experienced very mild or mild levels of
severity (61%, n=72). Less than 4% (n=32) out of 803
TL clients reported a moderate or severe level of
complication which required medical attention.
IUD: The most commonly reported side effects were
pain (11%, n=42) and bleeding (11%, n=41) up to day
15 after IUD insertion (see Table 7). Five percent
(n=18) experienced abdominal swelling and / or pain,
and less than one percent (n=2) complained of having
a urinary problem. One woman experiencing
prolonged bleeding said that she was going to get the
IUD removed. Compared to TL, which involves a (small

TABLE 6: Types of side effects / complications and severity reported by TL clients 15 days post procedure (n=803)
Side effect /
complication

Level of severity %(n=803)

Total
%(n)

Very mild
%(n)

Mild
%(n)

Moderate
%(n)

Severe
%(n)

Pain in the wound

2.8 (23)

1.0 (7)

3.0 (24)

-

6.7 (54)

Abdominal pain

2.9 (24)

2.0 16

1.2 (10)

-

6.2 (50)

Wound did not heal /
infection

0.7 (6)

0.2 (2)

0.2 (2)

-

1.2 (10)

Wound oozing blood

0.1 (1)

0.1 (1)

0.1 (1)

0.1 (1)

0.5 (4)

Urinary problem

0.1 (1)

-

0.1 (1)

-

0.2 (2)

Blood clot

0.1 (1)

-

-

-

0.1 (1)

56

26

38

1

121

5.8 (47)

3.1 (25)

3.8 (31)

0.1 (1)

14.8 (119)

Total number of
complications
Total women
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TABLE 7: Types of side effects / complications and severity reported by IUD clients 15 days post procedure (n=369)
Side effect /
complication

Level of severity %(n)

Total
%(n)

Very mild
%(n)

Mild
%(n)

Moderate
%(n)

Severe
%(n)

Pain

5.7 (21)

2.4 (9)

2.4 (9)

0.8 (3)

11.4 (42)

Bleeding (menstrual)

6.2 (23)

1.6 (6)

2.7 (10)

0.5 (2)

11.1 (41)

Abdominal swelling /
pain

3.5 (13)

0.5 (2)

0.5 (2)

0.3 (1)

4.9 (18)

Urinary problem

0.5 (2)

-

-

-

0.5 (2)
0.8 (3)

IUD expulsion
Total complications
reported
Total women

59

17

21

6

103

12.0 (45)

4.0 (15)

4.0 (15)

1.0 (4)

21.4 (79)

and quick) surgical procedure, IUD insertion does not
require a surgical procedure and is therefore
considered less invasive. However, a higher proportion
of IUD clients reported severe side effects, such as
pain, bleeding and abdominal pain (1%, n=4). Three
women (1%) reported that their IUD had come out by
day 15. Among the 79 women who reported any side
effects, the majority experienced very mild or mild
level of severity (76%, n=60), and 24% (n=19) said
their side effects were moderate or severe and
required medical attention. In total 5% (n=19) out of
369 IUD clients reported a moderate or severe level of
side effect which required medical attention.

4.7 Follow up care and health seeking
behaviour by day 15
At the day 15 follow up interview women were also
asked if they had sought medical care / advice or
self-medicated in response to any of the side effects
8

they had experienced. This question was asked to all
women regardless of what level of severity of side
effects they had experienced (which is also based on
the level of intervention sought to help address these
symptoms), in order to determine where these women
went for medical care.
5% of TL clients and 8% of IUD clients sought further
medical care in addition to the follow up care advice
and pain relief medication they were given as they left
the outreach service. Among those TL and IUD clients
who had reported any side effects and / or
complications (n=119 and n=87 respectively), one third
of both TL clients (34%, n=41) and IUD clients (32%,
n=28) sought medical attention. The majority of women
went to a government health centre for follow up care,
followed by the MSI clinic for IUD clients and ANM and
MSI IPC for TL clients. Although it is not known what
medications were purchased, a smaller number of
clients self-medicated by buying medicines from
pharmacies / drug shops or visiting a private clinic
(see Table 8).

In the level of severity definitions applied to measuring side effects a “mild” level could also include if a woman needed to self-medicate by buying pain
relief from a pharmacy or drug store. Note that levels moderate and severe included seeking medical care from a health provider such as a nurse,
private clinic or hospital.
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TABLE 8: Health seeking behaviour among women up to day 15 following TL and IUD procedure
Health seeking behaviour

Tubal ligation clients
(n=803) % (n)

IUD clients
(n=369) % (n)

94.8 (762)

93.0 (341)

Self medicated

0.8 (7)

1.3 (5)

Government HC / hospital

2.8 (23)

3.7 (14)

Private clinic

0.3 (3)

0.5 (2)

MSI clinic (static clinic)

0

1.8 (7)

Others (ANM, MSI IPC)

0.9 (8)

0

Total women sought care / advice

5.1 (41)

7.5 (28)

Did not seek care

Resumption of normal activities and work
Among TL clients 94% (n=757) reported that they
returned to work by the 15th day following their
procedure. Being able to return to work for IUD clients
was slightly more rapid than TL clients with 96%
(n=359) resuming their normal activities by day 15.
Approximately 4% of women reported that they could
not return to work for an average of 20 days.

4.8 IUD discontinuation by day 90 post
procedure
During the follow up visit on day 90 IUD clients were
asked about removal or expulsion of their IUD. Out of
the 393 IUD clients who were interviewed at day 90,
92% were still using the method. Thirty two women
(8%) who attended the follow up interview on day 90
had discontinued their IUD (see Figure 5). Of these 32
women, 16% (n=5) reported that their IUD had been
expelled and 84% (n=27) had had their IUD removed.
Of the women whose IUD had come out, three of these
women had reported the expulsion of their IUD at the
time of the day 15 interview. The majority of women
had their IUD removed at the health centre where the
outreach services was carried out (48%, n=13); others
sought their removal from a private nurse or doctor
(41%, n=11) and a public health facility (7%, n=2). One
woman had removed the IUD by herself.

Women gave multiple reasons for wanting to have the
IUD removed after 3 months. Out of the 27 women, the
main reason given for removing their IUD was due to
bleeding (n=27), feeling weak (n=19), discomfort during
intercourse (n=6), husband objected (n=4), fear the
IUD may have moved inside the body (n=3), fear will
cause cancer (n=3), and wanted to have another child
(n=1). There was also one report of IUD failure with
one woman getting pregnant and consequently getting
the device removed.
Among the women who decided to have their IUD
removed or expelled (n=32) and still did not want to get
pregnant, only 15 women switched to an alternative
method by day 90. Methods that these women started
to use were TL (n=5), contraceptive pill (n=7) and
condom (n=3).

Side effects reported at day 90 post
procedure
Just over half of women (54%, n=195) who still had
their IUD when interviewed on day 90 said they did not
experience any side effects or continuing problems
associated with their IUD. Out of the women who did
report side effects (46%, n=166), the most frequently
reported problem was menstrual bleeding problems
and abdominal pain (see Figure 6).
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FIGURE 4: Flow chart showing IUD discontinuation by day 90 among IUD study cohort
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FIGURE 5: Self reporting of continued side effects of IUD at day 90 (% of women) (n=393)
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4.9 Client Satisfaction
Client satisfaction was recorded at day 15 and day 90
among IUD clients. Overall satisfaction with the
outreach service was the same for both groups of
women accessing TL and IUD services, with 98% of
clients saying that the quality of services they received
was either as expected or better than expected. 1.5%
(n=6) of IUD clients were dissatisfied with the service
due to the attitude of the doctor. Reasons cited by the
small number of TL clients who were not satisfied with

the service included lack of transport to the site, no
provision of blankets and insufficient financial
compensation for travel.
Women were also asked on the day of the procedure if
they would recommend the method they received to a
friend: 91% (n=792) of TL clients said they would
recommend TL to a friend and 86% of IUD clients
(n=345). On day 90 the proportion of women who said
they would recommend the IUD method to a friend
decreased to 83% (n=326).

Discussion and recommendations

5. Discussion and
recommendations
The study has shown that MS India provides TL and
IUD contraceptive methods safely and effectively via
mobile outreach in rural areas of Rajasthan, with low
levels of minor complications and discontinuation, and
a high level of user satisfaction. Furthermore the
results indicate that MS India’s outreach services are
reaching under-served populations and addressing the
contraceptive unmet needs of poor and marginalised
men and women in the state of Rajasthan, with the
majority of TL and IUD clients living in rural areas (81%
and 72%), having never attended school (53% and
30%), and belonging to disadvantaged groups
(classified in India as Other Backward Classes; 53%
and 62%). Although the findings showed that the
majority of TL and IUD clients came from households
with a high SLI (TL 44% and IUD 61%), the proportion
of TL clients who have a low SLI (25%) is comparable
to the proportion of the population in Rajasthan who
are of low income level households (26%)9.[12] A
higher proportion of TL clients than IUD clients are
from households with a low or medium SLI (56% and
39%). Prior to receiving LARC or PM via outreach
services, 73% of TL clients and 54% of IUD clients
were not using any form of contraception, and 63% of
TL clients and 41 % of IUD clients had never used
contraception before. The study did not collect data on
what method those using contraception had been
using prior to receiving their LARC or PM method. The
majority of women choosing to have a TL had two to
three children (76%) and the majority of IUD clients
had one to two children (59%) demonstrating the
importance of expanding contraceptive choices for
women in hard to reach areas who wish to space as
well as limit the number their number of births.
Women learn about contraception mainly from the
government ANM, spouses or community health
workers. While a majority of women were able to name
family planning methods, the study did not measure
their level of understanding of these different methods,
which is a limitation. Knowledge of IUDs was low, and
the fact that 22% of IUD discontinuations were related
to myths and misconceptions around IUDs (for
example causing cancer or moving in the body)
demonstrates the need to provide more
comprehensive information about this method.
The main decision women gave for visiting MS India’s
outreach sites were because these services were free
9

and medical personnel were available. A large
proportion of women also reported the influential role
of their husbands or other family member in their
decision to adopt a TL or IUD. This highlights the
important role these people play in women’s
contraceptive decision making and the need for
outreach services to fully incorporate them in
educational activities to ensure both men and women
are fully informed about all contraceptive methods
available.

Incidence of side effects and
complications
The reported incidence of side effects and
complications in this study are not dissimilar to those
documented in the published literature. One third of all
women who had an IUD fitted said they experienced
some side effects following their procedure (32%,
n=94). Side effects experienced by women following
insertion of an IUD were generally mild to moderate
with less than 1% (n=2) reporting severe pain. At day
15, one in four women who had an IUD fitted (23%,
n=87) reported still experiencing at least one type of
side effect, with 1% (n=4) reporting a severe
complication relating to pain, bleeding and abdominal
pain / swelling. According to the literature,
complications during IUD insertion, such as cervical
laceration or uterine perforation are rare. [5, 15]
However, most women experience some minor side
effects such as changes in menstrual cycle and pain.
In a similar study conducted in 2010 by MSI among
clients receiving LARCs and PMs in outreach settings
in Uganda, it found 3% of IUD clients experience
severe side effects immediately after insertion and
1.9% experiencing minor complications at day 15. [6]
In another study carried out in 2009 in a clinical
setting, 9% of the 1,947 participants reported serious
pain in the first nine weeks of IUD use. [19] In this
study, even though the cases were not verified by a
medical practitioner, they highlight important areas to
be addressed.
One third of women who adopted a TL also
experienced side effects following their procedure
(35%, n=308) with the majority being described as mild
to moderate, and 2% (n=18) reporting severe pain. At
day 15 following the procedure, 15% (n=119) of TL

As documented in the DLHS3, for 2007-2008 survey the SLI index for the state of Rajasthan was low 25.5%; medium 29.5%; and high 28.8%.
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clients reported still experiencing at least one type of
side effect. Studies have shown that TL is generally
associated with low levels of minor complications
(1-4%), such as wound infections and small
haematoma which can be resolved easily and rapidly.
[10] For example, in the same study cited above
among MSI clients receiving LARCs and PMs in
outreach settings in Uganda, it found 1% of TL clients
experienced minor complications at the day 15 follow
up interview and a further 6% experienced frequent
pain.[6] In this study, 13% (n=118) of TL clients
reported very mild-moderate complications at day 15
and only 0.1% (n=1) reported severe complications
related to bleeding at the site of the wound.

IUD discontinuation
All IUD insertions were interval insertions. In the
current study a total of 8% (n=32) of IUD clients had
discontinued their IUD at day 90. Of these women 1%
(n=5) reported their IUD had been expelled. This is
comparable with other published studies that have
shown the proportion of women experiencing
expulsion of the IUD ranging from less than 1% to 10%
annually, although it is reported that most of these
occur within the first three months. [5, 11] There is
evidence to suggest that correct insertion technique
can reduce the rate of expulsion. [5]
A relatively small proportion, 7% (n=27) of women
decided to have their IUDs removed by day 90.
However this removal rate is slightly higher than that
reported in other studies conducted in similar nonclinical settings: the MSI outreach LARCs and PM
study in Uganda found an IUD removal rate of 6% at
90 days; [6] and the results of a retrospective multicountry study assessing discontinuation rates of IUDs
revealed 3% and 5% of IUD clients had IUDs removed
within three months in Pakistan and Myanmar
respectively.[9] In this study, women who had their
IUD removed said they did so due to bleeding (n=27),
feeling weak (n=19) or discomfort and pain (n=6).
Among the women who discontinued their IUD only
half of these women switched to an alternative method
of contraception which highlights the need to have
mechanisms in place for appropriate follow up and
counselling for alternative methods. One case of
method failure was reported; the woman became
pregnant with her IUD in situ and therefore had it

removed. This case was recorded in the 90 day follow
up.
It may be possible to reduce discontinuation by
strengthening counselling so that women are aware of
expected side effects and are informed that these
should dissipate over time. Expected side effects
should be clearly distinguished from those that are not
expected, are serious and require women to seek
medical help. Qualitative interviews among the IPC
also revealed that the prevailing myths and
misconceptions about the safety and efficacy of the
IUD (and vasectomy) - such as the IUD causing
cancer, or that it can float around the body, and that
vasectomy is unsafe for a man - are a barrier for men
and women to adopt these methods. Campaigns could
be developed to dispel these myths and increase
uptake and continuation of this effective method.
Despite MS India’s standard follow up care process,
including visits by the government ANM and provision
of pain relief and other medication, one third of TL and
IUD clients who reported side effects (TL n=38; IUD
n=28) still required post procedural care and resorted
to seeking further medical advice or self-medicated to
treat their on-going side effects. Post procedure follow
up care services may need to be reviewed to ensure
that the provision of personnel and supplies are
consistently available in all outreach areas.
High client satisfaction ratings among TL and IUD
methods and a willingness of women to recommend
the outreach services to others are encouraging.
Satisfaction among users of IUD declined slightly from
day 15 to day 90 which may indicate a need for more
counselling regarding the duration of some expected
side effects.

Limitations of the study
This service evaluation has several limitations.
1.		 The SLI used in this study is based on different
measures of poverty from the tool used in the MSI
Exit Interview Survey (used across the MSI
partnership). While this provides a sufficient
measure in the India context it does not provide a
reliable comparison with other MSI programmes or
other poverty data routinely collected by MS India.
The data in this survey shows MS India reaching
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women of more high income level households
which is at odds with MSI data that demonstrates
that a higher proportion of clients are poor. This
may be more a reflection of the different definitions
and methods used to determine “poor” than to
suggest the clients included in this study are of a
different socio-economic status than the usual
profile of MS India’s outreach programme in
Rajasthan.
2.		 Types of side effects and severity of side effects as
well as IUD expulsion were self-reported and not
verified by medical personnel, which may have
resulted in some over reporting. However, these
self-reports reflect the actual experiences of
women and should be not be underestimated in
efforts to improve counselling and awareness
raising activities around long acting reversible and
permanent contraceptive methods.
3.		 The follow up period of 15 days and then 90 days
for IUD was relatively short, and therefore the study
does not provide a good reflection of longer term
side effects, such as changes in menstrual
bleeding which may emerge over time, or of
discontinuation behaviours over a longer term. It
would also have been informative to have recorded
the actual number of days it took both TL and IUD
clients to recover and resume their normal activities
to further verify the severity of side effects and
impact on women’s lives.
4.		 Due to the small sample size (related to the
duration and available resources for the study) it
was not possible to further analyse the
characteristics of women who did experience
complications and discontinued their IUD. As with
other prospective studies measuring post
procedure outcomes, without strict medical
verification and control, it is difficult to differentiate
side effects / complications as a result of the
procedure from symptoms relating to the clients’
conditions or living environment that may
exacerbate complications, such as post procedure
wound care. Therefore for this study it is difficult to
determine the exact cause of the (small) number of
complications.
5.		 Clients were asked about satisfaction with the
service in general but not specifically about
different aspects of the service such as
consultation, counselling, procedure, pain

management and recovery, nor about satisfaction
with the particular method adopted.

5.1 Conclusions
The study demonstrates the safety and effectiveness
of providing TL and IUDs through MS India’s mobile
outreach services in the state of Rajasthan, and the
importance of continuing to use this service model to
increase access and choices for poor men and women
living in rural areas. By providing TLs and IUDs in
underserved, hard to reach areas, MS India
significantly contributes to the improvement of
Rajasthan’s overall sexual and reproductive health
service provision. This service evaluation has also
helped to identify areas to strengthen and improve MS
India’s outreach model, as well as to be considered by
other mobile outreach programmes.

5.2 Recommendations
It is recommended that the MS India program consider
the following:
•		 Strengthen counselling to increase client
awareness of expected side effects of LARCs and
PMs to help reassure new-users of these
symptoms, how to manage them and to emphasise
that these will dissipate in time. Counselling also
needs to clearly distinguish between expected and
unexpected side effects of LARCS and PMS and to
more clearly outline what to do if complications
arise. This can help to reduce women seeking
unnecessary medical care and to ensure women
have sufficient information on likelihood and
duration of side effects to make an informed
decision to continue with or discontinue their IUD.
•		 To address some of the factors cited by women
who had their IUD removed, as well as to
encourage other women to adopt this effective,
reversible method of family planning, the program
could benefit from conducting further qualitative
research to explore the myths surrounding longacting reversible methods and develop campaigns
to try to dispel misconceptions and increase uptake
and continuation.
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•		 All awareness raising activities for outreach
services and counselling about LARCs and PMs
need to acknowledge and involve the role of the
husband and other key family members who
influence women’s decision making about family
planning. Whilst informed consent is that of the
woman’s it is important that close family members
are well informed about all contraceptive methods
available as well as post-procedure care.
•		 MS India should continue to monitor the clinical
outcomes of TL and IUD clients attending outreach
services including monitoring contraceptive
compliance so that women who are considering or
have already had the IUD removed due to side
effects, and who still have an unmet need, receive
additional counselling to help them deal with their
symptoms better or alternatively are offered a
different method of contraception.
•		 Continue to provide supportive clinical supervision
to outreach teams and review post-procedure
counselling and care. In particular, ensure clients
are provided adequate analgesic medication
following the procedure and understand how to
check if their IUD is in place.
•		 Continue to establish and maintain important
networks with other health providers who are able
to address complications and side effects
effectively.
•		 As a reproductive health right for all women MS
India should continue to advocate for the
registration of implants in India and the expansion
of access to contraceptive injectables in the public
sector, to enable women to have more choice of
family planning methods.

5.3 Evidence to Action: Marie Stopes
India response to recommendations
Following the evaluation of MS India’s outreach
services which were conducted by the Population
Council in India in 2012, MS India have incorporated a
number of the recommendations into routine
programming in order to improve access and quality of
the outreach services:

•		 In order to strengthen all aspects of counselling on
all methods, an intensive three day training for all
the field level staff was facilitated and concluded. In
addition, the recommendation to increase
awareness among clients of expected side effects
of LARCs and PMs has been taken on board, with
additional focus on this area during provider
training. To improve post procedure counselling
and follow up, a new system has been instituted
that ensures a 24 hour follow-up. The nurses in the
clinical outreach teams have been provided with a
mobile handset to ensure that the calls are made
en-route to the outreach site the following day. This
follow-up ensures that the team is better connected
with the clients, and helps them understand any
issues that they may have with the method
provided. Post procedure counselling is also being
strengthened through a mobile phone SMS-based
project, currently being trialled with SIFPO-MSI
funding, which gives consistent and systematic
reminders to the nurses to improve post procedure
care and counselling.
•		 MSI has evolved its approach to outreach to
include the sub-health centre level, so that IUD
services are now available at the sub centre level.
Readier access to IUD services has increased
uptake.
•		 All doctors and the nurses have also been trained
on IUD insertions to ensure quality services.
•		 Internal audits to assess quality of services
provided at all outreach sites have now been
systematically rolled out. Every team is reviewed
once a quarter by the technical quality team.

MS India continues to work to ensure that the safety
and effectiveness of its outreach programme is
expanding choice and access to contraception for poor
men and women living in rural and hard to reach areas
of India.
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